Abi Manesh, Kamini Walia, Taslimarif Saiyed, Balaji Veeraraghavan, David L Paterson
Antibiotic development has historically been concentrated in high-income countries. We discuss how India is emerging as an important centre for antimicrobial development, and the implications for global health and equity of access to life-saving therapies.